Revvity (RVTY) Cash from Financing Activities (2009 - 2026)
Revvity (RVTY) reported Cash from Financing Activities of -$88.9 million for Q2 2026, up 45.68% on a YoY basis from -$61.0 million in Q2 2025, and up 49.58% quarter-over-quarter from -$176.3 million in Q4 2025.
Revvity (RVTY) Cash from Financing Activities (2009 - 2026) Analysis & Trends
Revvity has reported Cash from Financing Activities for 18 years, with the latest figure at -$88.9 million in Q2 2026.
- For the quarter ending Q2 2026, Cash from Financing Activities rose 45.68% year-over-year to -$88.9 million; the trailing twelve-month figure through Apr 2026 stood at -$782.8 million (up 37.72% YoY), and the FY2025 full-year result was -$857.5 million, up 23.99% from the prior year.
- Cash from Financing Activities for Q2 2026 stood at -$88.9 million, up from -$176.3 million in the prior quarter.
- The five-year high for Cash from Financing Activities was -$19.6 million in Q4 2023, with the low at -$3.7 billion in Q1 2023.
- Historically, Cash from Financing Activities has averaged -$461.9 million across 5 years, with a median of -$176.3 million in 2025.
- Annual changes were most pronounced in 2023 — Cash from Financing Activities soared 99.48% — and 2025, when it plunged 1041.63%.
- Revvity's Cash from Financing Activities stood at -$164.9 million in 2022, then jumped by 88.1% to -$19.6 million in 2023, then plunged by 883.94% to -$193.0 million in 2024, then grew by 8.64% to -$176.3 million in 2025, then soared by 49.58% to -$88.9 million in 2026.
- The last three Cash from Financing Activities figures came in at -$88.9 million (Q2 2026), -$176.3 million (Q4 2025), and -$215.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | -213.00 Mn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 1.09 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 46.00 Mn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | -211.43 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | -144.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | 3.76 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | -433.00 Mn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | -251.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | -114.33 Mn |
| 10 | Revvity | 11.63 Bn | 10.77 Bn | 387.66 Mn | -88.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 5, 2026 | -88.90 Mn |
| Apr 5, 2026 | -88.90 Mn |
| Dec 28, 2025 | -176.31 Mn |
| Dec 28, 2025 | -176.31 Mn |
| Sep 28, 2025 | -215.07 Mn |
| Sep 28, 2025 | -215.07 Mn |
| Jun 29, 2025 | -302.48 Mn |
| Jun 29, 2025 | -302.48 Mn |
| Mar 30, 2025 | -163.66 Mn |
| Mar 30, 2025 | -163.66 Mn |
| Dec 29, 2024 | -192.99 Mn |
| Dec 29, 2024 | -192.99 Mn |
| Sep 29, 2024 | -873.74 Mn |
| Sep 29, 2024 | -873.74 Mn |
| Jun 30, 2024 | -26.50 Mn |
| Jun 30, 2024 | -26.50 Mn |
| Mar 31, 2024 | -35.01 Mn |
| Mar 31, 2024 | -35.01 Mn |
| Dec 31, 2023 | -19.61 Mn |
| Dec 31, 2023 | -19.61 Mn |